Your browser doesn't support javascript.
loading
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Kimby, Eva; Lockmer, Sandra; Holte, Harald; Hagberg, Hans; Wahlin, Björn E; Brown, Peter; Østenstad, Bjørn.
Affiliation
  • Kimby E; Unit of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Lockmer S; Unit of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Holte H; Unit of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Hagberg H; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Wahlin BE; KG Jebsen Center for B-Cell Malignancies, Oslo, Norway.
  • Brown P; Department of Oncology, Academic Hospital, Uppsala, Sweden.
  • Østenstad B; Unit of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.
Br J Haematol ; 191(5): 738-747, 2020 12.
Article in En | MEDLINE | ID: mdl-32410260

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Lymphoma, Follicular / Rituximab Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Lymphoma, Follicular / Rituximab Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2020 Document type: Article